144 related articles for article (PubMed ID: 6138811)
1. Chemical communication in the CNS: neurotransmitters and their function.
Bloom FE
Prog Brain Res; 1983; 58():3-9. PubMed ID: 6138811
[No Abstract] [Full Text] [Related]
2. Regulation of glycogenolysis by neurotransmitters in the central nervous system.
Magistretti PJ
Diabete Metab; 1988; 14(3):237-46. PubMed ID: 2900788
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system effects of the neurohypophyseal hormones and related peptides.
de Wied D; Diamant M; Fodor M
Front Neuroendocrinol; 1993 Oct; 14(4):251-302. PubMed ID: 8258377
[TBL] [Abstract][Full Text] [Related]
4. [Vasopressin as a neurotransmitter and neuromodulator].
Kosekova G; Paneva R; Sirakov L
Eksp Med Morfol; 1993; 31(1-2):35-41. PubMed ID: 7903072
[TBL] [Abstract][Full Text] [Related]
5. The effects of vasopressin on memory processes: the role of noradrenergic neurotransmission.
Kovács GL; Bohus B; Versteeg DH
Neuroscience; 1979; 4(11):1529-37. PubMed ID: 42026
[No Abstract] [Full Text] [Related]
6. Neurotransmitter interactions related to central dopamine neurons.
Lloyd KG
Essays Neurochem Neuropharmacol; 1978; 3():129-207. PubMed ID: 30628
[No Abstract] [Full Text] [Related]
7. [Cholecystokinin and vasoactive intestinal polypeptide (VIP) in the central nervous system].
Krowicki Z; Sadowska-Krowicka H
Postepy Hig Med Dosw; 1983; 37(1):75-85. PubMed ID: 6138762
[No Abstract] [Full Text] [Related]
8. Vasoactive intestinal polypeptide: functional aspects.
Fahrenkrug J; Emson PC
Br Med Bull; 1982 Sep; 38(3):265-70. PubMed ID: 6129023
[No Abstract] [Full Text] [Related]
9. VIP: Possible functions as a neural peptide.
Said SI; Giachetti A; Nicosia S
Adv Biochem Psychopharmacol; 1980; 22():75-82. PubMed ID: 6104904
[No Abstract] [Full Text] [Related]
10. Effects of oxytocin and vasopressin in the central and in the autonomic nervous system. Interactions with other presumptive neurotransmitters.
Dreifuss JJ; Kiraly M; Dolivo M; Wuarin JP; Raggenbass M
Regul Pept Suppl; 1985; 4():165-71. PubMed ID: 2865771
[No Abstract] [Full Text] [Related]
11. Neuropeptides in cardiovascular control.
Ganong WF
J Hypertens Suppl; 1984 Dec; 2(3):S15-23. PubMed ID: 6400363
[TBL] [Abstract][Full Text] [Related]
12. Adaptive changes of neurotransmitter receptor mechanisms in the central nervous system.
Schwartz JC; Llorens Cortes C; Rose C; Quach TT; Pollard H
Prog Brain Res; 1983; 58():117-29. PubMed ID: 6138808
[No Abstract] [Full Text] [Related]
13. Neuropeptide effects on brain development.
Handelmann GE
J Physiol (Paris); 1985; 80(4):268-74. PubMed ID: 2422355
[TBL] [Abstract][Full Text] [Related]
14. [Regulation of cerebral circulation by neurotransmitters].
Jia WG
Sheng Li Ke Xue Jin Zhan; 1984 Jul; 15(3):214-7. PubMed ID: 6151253
[No Abstract] [Full Text] [Related]
15. Neurobiology of piperidine: its relevance to CNS function.
Kasé Y; Miyata T
Adv Biochem Psychopharmacol; 1976; 15():5-16. PubMed ID: 799462
[TBL] [Abstract][Full Text] [Related]
16. Peptides and neuronal function.
Gainer H
Adv Biochem Psychopharmacol; 1976; 15():193-210. PubMed ID: 15415
[No Abstract] [Full Text] [Related]
17. Cholecystokinin and vasoactive intestinal polypeptide in the mammalian CNS: distribution and possible physiological roles.
Emson PC; Hunt SP; Rehfeld JF; Golterman N; Fahrenkrug J
Adv Biochem Psychopharmacol; 1980; 22():63-74. PubMed ID: 6994447
[No Abstract] [Full Text] [Related]
18. Arginine vasopressin as a central neurotransmitter.
Riphagen CL; Pittman QJ
Fed Proc; 1986 Aug; 45(9):2318-22. PubMed ID: 2874053
[TBL] [Abstract][Full Text] [Related]
19. An overview of neuropeptides.
Krieger DT
Res Publ Assoc Res Nerv Ment Dis; 1986; 64():1-32. PubMed ID: 2873634
[No Abstract] [Full Text] [Related]
20. On the molecular mechanism of adrenocorticotrophic hormone in the CNS: neurotransmitters and receptors.
Pranzatelli MR
Exp Neurol; 1994 Jan; 125(1):142-61. PubMed ID: 7905835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
